There is no established safe dose of kratom. The FDA has not approved kratom for any use, and no regulatory body has set a recommended dosage. That said, millions of people use kratom, and understanding the dose ranges associated with different effects and risks can help you make more informed decisions.
Dose Ranges and Their Effects
Kratom produces distinctly different effects depending on how much you take. At low doses, between 1 and 5 grams of dried leaf powder, it acts as a stimulant, producing increased energy, alertness, and sociability. At higher doses, between 5 and 15 grams, the effects shift toward sedation, pain relief, and euphoria. Doses above 15 grams can produce effects that resemble opioid overdose, including dangerously slowed breathing.
These ranges come from observational data, not controlled clinical trials. Your individual response depends on body weight, tolerance, the specific kratom product, and whether you’ve eaten recently. Effects typically begin within about 50 minutes of ingestion and can last a full day. The primary active compound has a terminal half-life of roughly 23 hours, meaning it stays in your system much longer than most people assume. Redosing before the first dose clears can lead to accumulation and unpredictable effects.
Why the Same Dose Can Be Wildly Different
One of the biggest safety issues with kratom is product inconsistency. Native kratom leaf powder contains up to 2% of its primary active alkaloid by weight. But concentrated extract products, which are increasingly common in Western markets, can contain 40% or more of that same compound. That’s a 20-fold difference. A 2-gram serving of extract could deliver as much active alkaloid as 40 grams of plain leaf powder.
Because kratom is not regulated as a drug, supplement, or food additive in the United States, there’s no requirement for standardized labeling or third-party testing. Products have also been found to contain heavy metals like lead, and the FDA has linked more than 35 deaths to salmonella-contaminated kratom. You have no reliable way to verify what’s actually in a given product without independent lab testing.
How Kratom Acts on Your Brain
Kratom’s two key compounds interact with opioid receptors in your brain, but they do so differently. The more abundant one has relatively low binding strength and acts more like a blocker at human opioid receptors in lab settings, though in the body it appears to produce mild opioid-like effects combined with activity at other receptor types, including those involved in adrenaline signaling. The second compound, present in much smaller amounts, binds about nine times more strongly and activates opioid receptors as a partial agonist, producing effects more similar to traditional opioids.
This dual pharmacology is why low and high doses feel so different. It also means that concentrated extracts, which may contain elevated levels of the stronger compound, carry a disproportionately higher risk profile compared to plain leaf.
Liver Injury Risk
Regular kratom use has been linked to acute liver injury in at least several dozen documented cases. The pattern is fairly consistent: within 1 to 8 weeks of starting regular use, symptoms like fatigue, nausea, itching, dark urine, and yellowing of the skin appear. Liver damage from kratom tends to affect bile flow rather than directly destroying liver cells, and it can become severe.
In reported cases, people who stopped kratom generally recovered, though full resolution sometimes took months. Several case reports document recurrence: a person recovers, restarts kratom weeks or months later, and the liver injury returns, often worse the second time. One 58-year-old man recovered after stopping, then restarted kratom a year later and developed far more severe jaundice within a month. A 47-year-old man had a nearly identical pattern, with recurrence within days of restarting. These rechallenge cases strongly suggest kratom itself, rather than a contaminant, is the cause.
Dangerous Drug Interactions
Kratom interferes with liver enzymes that your body uses to break down many common medications. It strongly inhibits one enzyme pathway (CYP2D6) and acts as a time-dependent inhibitor of another (CYP3A), meaning the inhibition gets worse the longer kratom is in your system.
The practical consequence is that drugs normally processed by these pathways can build up to toxic levels in your blood. Researchers modeled what happens when someone takes just 2 grams of kratom alongside various medications. The sedative midazolam was predicted to reach nearly six times its normal blood concentration. The antipsychotic quetiapine was predicted to reach about 2.5 times normal levels. One kratom-related death involved quetiapine toxicity in a person who hadn’t taken enough quetiapine to overdose on its own, suggesting kratom blocked its breakdown. The sleep aid zolpidem and the anti-anxiety medication buspirone were also flagged, with buspirone potentially reaching 14 times its normal concentration.
If you take any prescription medication, especially psychiatric medications, sedatives, or pain relievers, combining them with kratom is particularly risky.
Overdose and Severe Toxicity
At toxic doses, kratom can cause rapid heart rate, high blood pressure, kidney failure, liver damage, seizure-like muscle jerking, severe metabolic imbalance, and respiratory failure requiring mechanical ventilation. In one published case, a patient developed temporary heart muscle damage from kratom toxicity alone.
CDC data from 2024 identified 413 drug overdose deaths across 43 jurisdictions where kratom was detected in toxicology reports. The critical context: the vast majority of these deaths involved other substances. About 73% involved at least one opioid, and 65% involved at least one stimulant. Only 4.4% of overdose deaths in the broader dataset involved neither opioids nor stimulants. Kratom-only fatal overdoses are rare but not nonexistent, and the risk climbs sharply when kratom is combined with other drugs.
Dependence and Withdrawal
Because kratom activates opioid receptors, regular use can produce physical dependence. The FDA lists substance use disorder as one of its primary safety concerns. Withdrawal symptoms resemble mild to moderate opioid withdrawal: muscle aches, irritability, insomnia, runny nose, and mood disturbances. The long half-life of kratom’s active compounds means withdrawal may be delayed compared to shorter-acting opioids, and symptoms can persist for several days. Higher doses and longer duration of use increase the likelihood and severity of dependence.
What “Safe” Realistically Means
No dose of kratom has been formally established as safe. The FDA considers it an adulterated product that is not lawfully marketed as a drug, dietary supplement, or food additive. For people who choose to use it anyway, lower doses of plain leaf powder (not extracts) carry less risk than higher doses or concentrated products. Avoiding other substances, especially opioids, sedatives, and medications processed by CYP3A or CYP2D6 enzymes, significantly reduces the chance of a dangerous interaction. Watching for early signs of liver problems, particularly dark urine, unusual fatigue, or yellowing skin in the first two months, and stopping immediately if they appear, has been the difference between recovery and serious harm in documented cases.